Related Experiment Video
Updated: Jun 22, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Micromanipulating cancer: microRNA-based therapeutics?
Fabio Petrocca1, Judy Lieberman
1Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
RNA Biology
|June 19, 2009
Summary
MicroRNAs regulate key cancer processes. Manipulating microRNA function offers a promising therapeutic strategy for cancer treatment by targeting cancer progression pathways.
Area of Science:
- Molecular biology
- Oncology
- Biotechnology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that play crucial roles in regulating gene expression.
- Dysregulation of miRNA expression is frequently observed in various human cancers.
- miRNAs are involved in fundamental cellular processes including differentiation, proliferation, survival, and metastasis.
Purpose of the Study:
- To review the therapeutic potential of manipulating microRNA function in cancer.
- To explore the opportunities and challenges associated with using miRNAs as cancer therapeutics.
- To discuss how targeting miRNA pathways can interfere with cancer progression.
Main Methods:
- Literature review of current research on microRNAs in cancer.
- Analysis of studies investigating miRNA mimics and inhibitors for cancer therapy.
- Exploration of key cancer pathways regulated by microRNAs.
Main Results:
- MicroRNAs are critical regulators of cancer cell behavior.
- Targeting miRNAs offers a novel therapeutic avenue for cancer treatment.
- Significant progress has been made in developing miRNA-based therapeutic strategies.
Conclusions:
- Harnessing microRNA biology presents a powerful strategy for cancer therapy.
- Overcoming obstacles in miRNA delivery and specificity is key to clinical success.
- Further research is needed to fully realize the therapeutic potential of miRNAs in oncology.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...